Language
Menu
About Us
Corporate OverviewOur LeadershipOur HistoryOur ValuesScience & InnovationCompliance & Ethics Program
Our Impact
Sustainability
Our Offerings
Generics & Complex GenericsInnovative MedicinesOur ProductsProduct Education
Our People
Our CultureCareer
 Contact Us
Linkdin profile
Close

Press Releases

November 28, 2024

Lupin Receives Tentative Approval from U.S. FDA for Sitagliptin and Metformin Hydrochloride Tablets

November 19, 2024

Lupin Receives Approval from U.S. FDA for Mixed Salts of a Single-Entity Amphetamine Extended-Release Capsules

November 19, 2024

Lupin Launches Bumetanide Injection, USP in the United States

November 8, 2024

Lupin Receives Tentative Approval from U.S. FDA for Raltegravir Tablets, USP

October 15, 2024

Lupin Launches First Generic of Pred Forte® in the United States

September 18, 2024

Lupin Receives Approval from U.S. FDA for Bumetanide Injection, USP

September 4, 2024

Lupin Launches Mirabegron Extended-Release Tablets in the United States

August 29, 2024

Lupin Launches Doxorubicin Hydrochloride Liposome Injection in the United States

August 27, 2024

Lupin Receives Approval from U.S. FDA for Brimonidine Tartrate Ophthalmic Solution, 0.1%

Previous Page12345678Next Page

Media

Rajalakshmi Azariah
Vice President & Global Head - Corporate Communications
rajalakshmiazariah@lupin.com
Smart Guide
CloseClose

Search Product

    Guide
    Consent to Collection CookieTest

    This website uses cookies to enhance your overall web browsing experience, provide you with ads tailored to your interests, and allow us to measure our audience and collect other analytical data about the use of our website.

    By clicking "Accept All" you consent to the collection of your personal information (which may include your Consumer Health Data) through 1st and 3rd party cookies (or similar). To edit your cookie preferences, use the options below.

    For more information, please visit our Privacy Statement.

    Accept All CookiesReject All Non-Essential CookiesCookie Preference Center

    Depending on where you live, you may also be able to exercise your right to opt out or withdraw your consent.Do Not Sell/Share My Personal Information.